Trademark: 85125581
Status Date
Monday, June 2, 2014
Filing Date
Thursday, September 9, 2010
Published for Opposition
Tuesday, March 1, 2011
Abandoned Date
Monday, June 2, 2014
5 Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, hemostatic agents, metabolic diseases, anti-viral diseases, oncologic diseases, and respiratory diseases
Jun 2, 2014
Abandonment Notice Mailed - No Use Statement Filed
Jun 2, 2014
Abandonment - No Use Statement Filed
Oct 9, 2013
Notice Of Approval Of Extension Request E-Mailed
Oct 8, 2013
Extension 5 Granted
Oct 3, 2013
Extension 5 Filed
Oct 3, 2013
Teas Extension Received
Mar 23, 2013
Notice Of Approval Of Extension Request E-Mailed
Mar 22, 2013
Extension 4 Granted
Mar 20, 2013
Extension 4 Filed
Mar 20, 2013
Teas Extension Received
Sep 25, 2012
Notice Of Approval Of Extension Request E-Mailed
Sep 24, 2012
Extension 3 Granted
Sep 21, 2012
Extension 3 Filed
Sep 21, 2012
Teas Extension Received
May 1, 2012
Notice Of Approval Of Extension Request E-Mailed
Apr 30, 2012
Extension 2 Granted
Mar 29, 2012
Extension 2 Filed
Apr 27, 2012
Case Assigned To Intent To Use Paralegal
Mar 29, 2012
Teas Extension Received
Mar 29, 2012
Teas Change Of Correspondence Received
Oct 14, 2011
Notice Of Approval Of Extension Request Mailed
Oct 12, 2011
Extension 1 Granted
Oct 12, 2011
Extension 1 Filed
Oct 12, 2011
Teas Extension Received
Apr 26, 2011
Noa Mailed - Sou Required From Applicant
Mar 1, 2011
Published For Opposition
Feb 9, 2011
Notice Of Publication
Jan 26, 2011
Law Office Publication Review Completed
Jan 21, 2011
Assigned To Lie
Dec 22, 2010
Approved For Pub - Principal Register
Dec 16, 2010
Assigned To Examiner
Sep 13, 2010
New Application Office Supplied Data Entered In Tram
Sep 13, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
